Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$48.22+0.22 (+0.46%)
Close on Nov 17, 2026Market cap $2.28BP/E 13.5Yield –
Prestige Consumer Healthcare ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Prestige Consumer Healthcare's ebitda for the twelve months ending Jun 30, 2026 was $322.53M, down 11.9% year over year. For fiscal 2026 it was $340.68M, down 7.2% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $373.10M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $340.68M | -7.2% |
| FY2025 | Mar 31, 2025 | $366.95M | -1.6% |
| FY2024 | Mar 31, 2024 | $373.10M | +3554.3% |
| FY2023 | Mar 31, 2023 | $10.21M | -97.2% |
| FY2022 | Mar 31, 2022 | $362.01M | +10.5% |
| FY2021 | Mar 31, 2021 | $327.57M | +2.3% |
| FY2020 | Mar 31, 2020 | $320.15M | +222.5% |
| FY2019 | Mar 31, 2019 | $99.28M | -60.1% |
| FY2018 | Mar 31, 2018 | $248.90M | +7.5% |
| FY2017 | Mar 31, 2017 | $231.44M | -18.5% |
| FY2016 | Mar 31, 2016 | $283.99M | +26.1% |
| FY2015 | Mar 31, 2015 | $225.30M | +11.5% |
| FY2014 | Mar 31, 2014 | $202.10M | -1.5% |
| FY2013 | Mar 31, 2013 | $205.12M | +80.6% |
| FY2012 | Mar 31, 2012 | $113.56M | +31.7% |
| FY2011 | Mar 31, 2011 | $86.25M | -3.9% |
| FY2010 | Mar 31, 2010 | $89.78M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $61.27M | -22.9% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $83.84M | -12.4% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $90.08M | -8.9% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $87.33M | -5.3% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $79.42M | -0.9% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $95.68M | +6.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $98.83M | +4.6% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $92.27M | -3.8% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $80.17M | -13.6% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $90.00M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $94.48M | -0.9% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $95.89M | +3.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $92.74M | -2.8% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$273.13M | -417.9% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $95.31M | +5.2% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $92.63M | +7.1% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $95.40M | -3.6% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $85.91M | +9.5% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $90.64M | +11.8% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $86.52M | +7.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $98.94M | +13.0% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $78.47M | -3.4% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $81.05M | -3.3% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $80.45M | +5.1% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $87.59M | +11.5% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $81.25M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $83.79M | -1.9% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $76.57M | -3.0% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $78.55M | -2.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$145.92M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $85.43M | -7.4% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $78.92M | -6.3% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $80.86M | -7.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$15.05M | -125.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $92.23M | +22.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $84.26M | +9.3% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $87.46M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $60.15M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $75.14M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $77.07M | – |
See a number that looks wrong?